Toxicity of nanomaterials

S Sharifi, S Behzadi, S Laurent, ML Forrest… - Chemical Society …, 2012 - pubs.rsc.org
Nanoscience has matured significantly during the last decade as it has transitioned from
bench top science to applied technology. Presently, nanomaterials are used in a wide …

Bone-targeted nanoparticle drug delivery system: an emerging strategy for bone-related disease

Y Chen, X Wu, J Li, Y Jiang, K Xu, J Su - Frontiers in Pharmacology, 2022 - frontiersin.org
Targeted delivery by either systemic or local targeting of therapeutics to the bone is an
attractive treatment for various bone metabolism diseases such as osteoporosis …

[HTML][HTML] Regulation of extracellular bioactive cations in bone tissue microenvironment induces favorable osteoimmune conditions to accelerate in situ bone …

Z Lin, D Shen, W Zhou, Y Zheng, T Kong, X Liu, S Wu… - Bioactive materials, 2021 - Elsevier
The design of orthopedic biomaterials has gradually shifted from “immune-friendly” to
“immunomodulatory,” in which the biomaterials are able to modulate the inflammatory …

[HTML][HTML] Bisphosphonate conjugation for bone specific drug targeting

KB Farrell, A Karpeisky, DH Thamm, S Zinnen - Bone reports, 2018 - Elsevier
Bones provide essential functions and are sites of unique biochemistry and specialized
cells, but can also be sites of disease. The treatment of bone disorders and neoplasia has …

Osteoimmunomodulatory nanoparticles for bone regeneration

J Wen, D Cai, W Gao, R He, Y Li, Y Zhou, T Klein… - Nanomaterials, 2023 - mdpi.com
Treatment of large bone fractures remains a challenge for orthopedists. Bone regeneration
is a complex process that includes skeletal cells such as osteoblasts, osteoclasts, and …

Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy

OM Ali, AA Bekhit, SN Khattab, MW Helmy… - Colloids and Surfaces B …, 2020 - Elsevier
Despite the clinical approval of few nanomedicines for cancer therapy, some drawbacks still
impede their improved efficiency including low drug loading, off-target toxicity and …

Nanomedicines for the treatment of hematological malignancies

AK Deshantri, AV Moreira, V Ecker… - Journal of Controlled …, 2018 - Elsevier
Hematological malignancies (HM) are a collection of malignant transformations originating
from cells in the primary or secondary lymphoid organs. Leukemia, lymphoma, and multiple …

Targeted delivery to bone and mineral deposits using bisphosphonate ligands

LE Cole, T Vargo-Gogola, RK Roeder - Advanced drug delivery reviews, 2016 - Elsevier
The high concentration of mineral present in bone and pathological calcifications is unique
compared with all other tissues and thus provides opportunity for targeted delivery of …

Interactions of PLGA nanoparticles with blood components: protein adsorption, coagulation, activation of the complement system and hemolysis studies

C Fornaguera, G Calderó, M Mitjans, MP Vinardell… - Nanoscale, 2015 - pubs.rsc.org
The intravenous administration of poly (lactic-co-glycolic) acid (PLGA) nanoparticles has
been widely reported as a promising alternative for delivery of drugs to specific cells …

Biomedical applications of bisphosphonates

EV Giger, B Castagner, JC Leroux - Journal of Controlled Release, 2013 - Elsevier
Since their discovery over 100years ago, bisphosphonates have been used industrially as
corrosion inhibitors and complexing agents. With the discovery of their pharmacological …